Marilyn Lamm

IBC Chair

Marilyn LG Lamm is a published scientist with expertise in reproductive endocrinology, cell signaling pathways, and cancer biology. She received her Ph.D. in Physiology from the University of Illinois, Champaign-Urbana. She did a postdoctoral fellowship at Northwestern University Feinberg School of Medicine in Chicago where she later joined the research faculty. Aside from research, she has extensive experience in the peer review process for research grants and scientific manuscripts at the national level. Having served leadership roles in critically important institutional regulatory committees including Chair of the Institutional Biosafety Committee (IBC) of the Ann and Robert H. Lurie Children’s Hospital, she is experienced in the review of study protocols in basic and clinical research including human gene therapy protocols. Dr. Lamm is highly committed to facilitating gene therapy research with utmost considerations to biosafety to eliminate human health disorders and diseases.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.